News

Bluebird Beats Investor Lawsuit Over FDA Black Box Warning
Bluebird Bio Inc. defeated allegations it misled investors over the terms regulators would apply for approving its sickle cell treatment, a federal judge ruled.
The National Law Review21h
Should Miller be Set Aside? Observations from a Recent U.S. Supreme Court Decision Regarding a Trustee’s Power to Set Aside Fraudulent Transfers
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ ...